Advertisement
Screener

Tenon Medical, Inc. (TNON) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Tenon Medical, Inc. Investing Cash Flow

Tenon Medical, Inc. (TNON) reported Investing Cash Flow of -$228.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13

  • Tenon Medical, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$172.00K.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$56.00K.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$192.00K, a 618.92% decline year-over-year.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$639.00K.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$1.02M.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$186.00K, a 103.03% decline from fiscal 2023.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $6.14M.
  • Tenon Medical, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$2.88M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30-$172.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$228.00K
10-Q · filed 2026-08-13
-$420.00K
derived: sum of 3 quarters · filed 2026-08-13
-$1.06M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$56.00K
10-Q · filed 2026-05-15
-$248.00K
derived: sum of 2 quarters · filed 2026-05-15
-$887.00K
derived: sum of 3 quarters · filed 2026-05-15
2025-12-31-$192.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$831.00K
derived: sum of 2 quarters · filed 2026-03-27
-$1.02M
10-K · filed 2026-03-27
2025-09-30-$639.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$831.00K
10-Q · filed 2025-11-13
2025-06-30-$192.00K
10-Q · filed 2026-08-13
2024-12-31$37.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$67.00K
derived: sum of 2 quarters · filed 2026-03-27
-$67.00K
derived: sum of 3 quarters · filed 2026-03-27
-$186.00K
10-K · filed 2026-03-27
2024-09-30-$104.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$104.00K
derived: sum of 2 quarters · filed 2025-11-13
-$223.00K
10-Q · filed 2025-11-13
-$315.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$119.00K
10-Q · filed 2025-08-13
-$211.00K
derived: sum of 3 quarters · filed 2025-08-13
$225.00K
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31-$119.00K
10-Q · filed 2025-05-13
-$211.00K
derived: sum of 2 quarters · filed 2025-05-13
$225.00K
derived: sum of 3 quarters · filed 2025-05-13
$1.35M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$92.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$344.00K
derived: sum of 2 quarters · filed 2025-03-26
$1.47M
derived: sum of 3 quarters · filed 2025-03-26
$6.14M
10-K · filed 2025-03-26
2023-09-30$436.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$1.56M
derived: sum of 2 quarters · filed 2024-11-14
$6.23M
10-Q · filed 2024-11-14
$8.57M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$5.80M
10-Q · filed 2024-08-13
$8.14M
derived: sum of 3 quarters · filed 2024-08-13
$6.82M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$4.67M
10-Q · filed 2024-05-15
$7.01M
derived: sum of 2 quarters · filed 2024-05-15
$5.69M
derived: sum of 3 quarters · filed 2024-05-15
-$2.49M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$2.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$1.02M
derived: sum of 2 quarters · filed 2024-03-29
-$7.16M
derived: sum of 3 quarters · filed 2024-03-29
-$2.88M
10-K · filed 2024-03-29
2022-09-30-$1.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$9.50M
derived: sum of 2 quarters · filed 2023-11-14
-$5.22M
10-Q · filed 2023-11-14
-$1.85M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$8.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
-$3.91M
10-Q · filed 2023-08-11
-$531.00K
derived: sum of 3 quarters · filed 2023-08-11
-$8.41M
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31$4.28M
10-Q · filed 2023-05-09
$7.65M
derived: sum of 2 quarters · filed 2023-05-09
-$228.00K
derived: sum of 3 quarters · filed 2023-05-09
-$228.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$3.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
-$4.50M
derived: sum of 2 quarters · filed 2023-03-10
-$4.50M
derived: sum of 3 quarters · filed 2023-03-10
-$4.50M
10-K · filed 2023-03-10
2021-09-30-$7.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$7.88M
derived: sum of 2 quarters · filed 2022-11-10
-$7.88M
10-Q · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$0.00
10-Q · filed 2022-08-12
2021-03-31$0.00
10-Q · filed 2022-06-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Profusa, Inc. (PFSA)United States$0.002B
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
NEXGEL, INC. (NXGL)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B